Results 51 to 60 of about 125,761 (305)
Cardiovascular disturbances and atherosclerosis risk Гасtore in systemic lupus erythematosus
Научно-практическая ревматология, 2004 Objective. To assess frequency and significance of atherosclerosis and connected with it cardiovascular disturbances (CVD) risk factors in pts wilh systemic lupus erythematosus (SLE). Material and methods.
T V Popkova +4 more
doaj +1 more source
SLE: reconciling heterogeneity [PDF]
Lupus Science & Medicine, 2019 Patients with SLE experience multiple, varied symptoms and laboratory abnormalities that occur in different combinations, at different points in time.1 A result of the heterogeneity is that studies on SLE employ several, sometimes conflicting, definitions of the illness.
Peter Izmirly +4 more
openaire +3 more sources
Arthritis Care &Research, EarlyView.Objective To support high‐quality, patient‐centered care for systemic lupus erythematosus (SLE), the American College of Rheumatology (ACR) developed evidence‐based measures incorporating clinical and patient‐reported outcome measures (PROMs). Using the Consolidated Framework for Implementation Research (CFIR), we conducted semistructured interviews ...
Catherine Nasrallah +13 more
wiley +1 more source
Neuropsychiatric manifstation in patient having SLE
Journal of Integrated Health Sciences, 2015 A 30 year old woman residing at Khargaon, M.P., presented with complaints of abnormal behavior, decreased sleep, unable to perform routine activity and headache in psychiatry OPD of Dhiraj General Hospital.
J D Lakhani +5 more
doaj +1 more source
Assessment of microRNA profile of kidney biopsies of patients with lupus nephritis [PDF]
Journal of Nephropathology, 2017 Background: The changes in some epigenetic elements such as microRNAs result in aberrant immune responses leading to production and secretion of nephritogenic autoantibodies as the main fundament of lupus nephritis (LN).
Tahereh Malakoutian +3 more
doaj +1 more source
, 2023 We analyze the law of the SLE tip at a fixed time in capacity parametrization. We describe it as the stationary law of a suitable diffusion process, and show that it has a density which is a unique solution of a certain PDE.
Oleg Butkovsky +5 more
core +1 more source
Arthritis Care &Research, EarlyView.Objective The aim of this study was to evaluate the sensitivity of the 2023 American College of Rheumatology (ACR)/EULAR classification criteria for antiphospholipid syndrome (APS) in a real‐world cohort of women diagnosed with primary obstetric APS (oAPS) and to assess their ability to identify patients at risk of future pregnancy complications ...
Francesca Ruffilli +10 more
wiley +1 more source
The socioeconomic burden of SLE [PDF]
Nature Reviews Rheumatology, 2009 Systemic lupus erythematosus (SLE) is a chronic, relapsing-remitting, multisystemic autoimmune inflammatory disorder that predominantly affects women of childbearing age. Much has been written about the clinical course and long-term damage associated with SLE, as well as the reduced life expectancy of patients with this condition.
Lau, CS, Mak, A
openaire +4 more sources
Arthritis Care &Research, EarlyView.People with systemic autoimmune and rheumatic diseases (SARDs) are at higher risk than the general population of experiencing adverse pregnancy and perinatal outcomes such as preeclampsia, intrauterine growth restriction, and maternal and/or fetal death.
Mehret Birru Talabi, Sonya Borrero
wiley +1 more source
Interleukin biomarkers as predictive tools for lupus nephritis grade and disease activity in systemic lupus erythematosus [PDF]
ARP RheumatologyBackground: Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple organs, particularly the kidneys. Interleukin (IL) biomarkers including IL-10 and IL17/23 axis play an important role in SLE pathogenesis.
Dalia S. Saif +5 more
doaj